Alphatec (NASDAQ:ATEC) Shares Rise 3.3% - Is Now the Time to Buy?

Alphatec Holdings, Inc. (NASDAQ:ATEC) saw its shares increase by 3.3% in mid-day trading on Wednesday. The stock reached a high of $9.80 and was last seen trading at $9.66. During the session, around 564,365 shares were exchanged, which is a significant drop of 42% compared to the average daily volume of 967,765 shares. The previous closing price was $9.35.

Recent Analyst Rating Changes

Several research firms have recently shared their views on Alphatec's stock. Barclays raised its price target for Alphatec shares from $19.00 to $20.00, maintaining an "overweight" rating as noted in a report released on November 19th. Meanwhile, Needham & Company LLC reiterated a "buy" rating with a target price of $13.00 in its research published on October 31st. Additionally, HC Wainwright also reaffirmed a "buy" rating and established a target price of $20.00, also on October 31st. Among research analysts, one maintains a hold rating, while a majority—eight analysts—recommend a buy. MarketBeat indicates that Alphatec has an average rating of "Moderate Buy" and a consensus price target of $17.11.

Overview of Alphatec's Financial Health

Alphatec currently shows a strong financial position with a current ratio of 2.32, a quick ratio of 1.15, and a debt-to-equity ratio of 30.21. The company boasts a market capitalization of $1.36 billion, coupled with a negative PE ratio of -7.47 and a beta of 1.41. The stock's fifty-day simple moving average stands at $9.29, while its 200-day average is $8.00.

Institutional Investor Activity

Various institutional investors have recently adjusted their shares in Alphatec. Van ECK Associates Corporation expanded its holdings by 11.8% during the second quarter, owning a total of 12,275 shares now valued at $128,000 after acquiring an additional 1,300 shares. Atria Investments Inc. also increased its position by 8.0% in the third quarter, reaching 19,609 shares valued at $109,000 following the purchase of 1,460 shares. Furthermore, Entropy Technologies LP raised its stake by 14.9%, owning 21,623 shares worth $120,000 after additional buying. Wrapmanager Inc. boosted its shareholding by 9.5%, resulting in 38,399 shares valued at $213,000. Lastly, Rhumbline Advisers increased their holdings by 2.6%, totaling 143,474 shares now worth $1,499,000. Overall, institutional shareholders hold 66.35% of Alphatec's stock.

About Alphatec Holdings

Alphatec Holdings, Inc. is a prominent medical technology company dedicated to developing advanced technologies for the surgical treatment of spinal disorders both in the United States and internationally. Their product line includes implants and instruments, largely supplied through third parties. Among their offerings is the Alpha InformatiX product platform, which features the EOS imaging system for full-body imaging, the VEA alignment mobile app for efficient alignment parameters, the SafeOp Neural InformatiX System for automated monitoring, and the Valence intra-operative system integrating navigation and robotics for spine procedures.

Investment Considerations

Before considering an investment in Alphatec, it's crucial to review all relevant information and perform due diligence. While the stock currently has a "Moderate Buy" rating, analysts highlight that there are alternative stocks with higher potential returns.

Alphatec, Stocks, Investing